Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study

UOBScholar Hub

Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/5577

Title:	Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study
Authors:	Atallah, Natalie J Warren, Hailey M Roberts, Matthew B Elshaboury, Ramy H Bidell, Monique R Gandhi, Ronak G Adamsick, Meagan Ibrahim, Maryam K Sood, Rupali Bou Zein Eddine, Savo Cobler-Lichter, Matthew J Alexander, Natalie J Timmer, Kyle D Atallah, Christine J Viens, Adam L Panossian, Vahe S Scherer, Allison K Proctor, Teddie Smartt, Sherrie Letourneau, Alyssa R Paras, Molly L Johannes, Sascha Wiemer, Jan Mansour, Michael K
Affiliations:	Faculty of Medicine
Issue Date:	2022-01-13
Publisher:	National Library of Medicine
Part of:	PLoS ONE
Volume:	17
Issue:	1
Abstract:	Coronavirus disease-2019 (COVID-19) is associated with a wide spectrum of clinical symptoms including acute respiratory failure. Biomarkers that can predict outcomes in patients with COVID-19 can assist with patient management. The aim of this study is to evaluate whether procalcitonin (PCT) can predict clinical outcome and bacterial superinfection in patients infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
URI:	https://scholarhub.balamand.edu.lb/handle/uob/5577
DOI:	10.1371/journal.pone.0262342
Open URL:	Link to full text
Type:	Journal Article
Appears in Collections:	Faculty of Medicine

19

checked on Apr 20, 2024

22

checked on Apr 25, 2024

Check